Articles Mentioning Growth Stocks

Results 1 - 10 of 1166 : 1 2 3 4 5 6 7 8 9 Next

Get RSS Feed for Growth

Investing | January 24, 2015

3 Turnaround Stories We're Watching in 2015

Three Motley Fool contributors look at some of the worst performers of last year and how their fortunes can change in 2015.

Investing | January 22, 2015

1 Move that Could Totally Crush Intel Corporation

A response to a claim that Intel should milk its next-generation processor for 3-4 years.

Investing | January 21, 2015

What Did Advanced Micro Devices, Inc. (AMD) Prove in the Fourth Quarter?

AMD's turnaround story hasn't exactly started yet. But new CEO Lisa Su just might have what it takes to get the company back on its feet again.

Investing | January 13, 2015

What Is the Die Size of Intel Corporation's Knights Landing Xeon Phi Processor?

A look at the potential die size and its cost structure implications of Intel's upcoming Xeon Phi processor.

Investing | January 13, 2015

Why Intel's Compute Stick Could Help Microsoft and Hurt ARM and Google

Here’s why Intel’s $149 Windows PC stick matters to ARM Holdings and Google.

Investing | January 13, 2015

2 Ways Advanced Micro Devices Inc.’s Carrizo Pulls Ahead of Intel Corporation’s Broadwell

Struggling Advanced Micro Devices manages to beat chip giant Intel to the punch in a few areas with its upcoming Carrizo chip.

Investing | January 12, 2015

Advanced Micro Devices, Inc. and Servers: What’s Going On Here?

A look at Advanced Micro Devices' server efforts thus far and what it plans to bring to market.

Investing | January 11, 2015

Should AbbVie Inc. Or Gilead Sciences Buy These Tiny Biotech Stocks?

AbbVie Inc and Gilead Sciences may want to consider Achillion Pharmaceuticals' and Regulus Therapeutics' intriguing hepatitis C drugs.

Investing | January 11, 2015

5 Predictions for Biotechnology Stocks in 2015

Celgene Corp, Alkermes, GW Pharmaceuticals, Gilead Sciences, and Hospira should all be on investors radar in 2015.

Investing | January 08, 2015

Great News! An Exciting New Drug for Depression May Be on the Way

In phase 3 trials, Alkermes' ALKS-5461 shows promise for the treatment of depression.

Results 1 - 10 of 1166 : 1 2 3 4 5 6 7 8 9 Next

Get RSS Feed for Growth